Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 14.44 Billion | USD 31.76 Billion | 9.28% | 2023 |
The global animal vaccines market size was worth around USD 14.44 billion in 2023 and is predicted to grow to around USD 31.76 billion by 2032 with a compound annual growth rate (CAGR) of roughly 9.28% between 2024 and 2032.
Vaccination has been one of the most important conciliations in disease prevention that has ever been developed.The effectiveness of vaccination is seen by the reduction in disease.Animal vaccines provide protection against various diseases such as rabies, feline panleukopenia, feline viral rhinotracheitis, feline calicivirus infection, canine distemper, canine parvovirus infection, and canine hepatitis. Hence, most of the animal doctors recommend vaccines depending on the type and severity of the disease.
Animal vaccines can be made available without large, controlled dispute studies that are mandatory prior to the release of human vaccines. Animal vaccines are controlled by the US Department of Agriculture, which hardly requires the vaccines to be shown to be safe and pure, and have a “reasonable expectation” of efficacy prior to their release.Nevertheless, the clinical relevancy or applicability of a particular vaccine may not necessarily be assured by the licensing process. This fact makes it easier for the manufacturers to provide animal vaccines and meet the rising demand in the global market.
The growth of global animal vaccines market is expected to boost owing to the increase in the livestock population and frequent occurrence of livestock diseases. In addition, factors such as rising prevalence of zoonotic diseases, various initiatives were taken up by different government agencies and animal associations, and the introduction of new vaccine types also impact the growth of the market in a positive way. Moreover, technological innovations, growing awareness regarding animal health in the emerging countries, etc. are some other factors boosting the market growth.
Based on the type of vaccine, the global animal vaccines market is segmented as inactivated vaccines, toxoid vaccines, live attenuated vaccines, subunit vaccines, and others. The others segment is further sub-segmented as conjugate vaccines, recombinant vaccines, and DNA vaccines. Of which, the DNA vaccines segment is anticipated to account for the highest growth in the near future.
On the basis of disease category, the global market is segmented as anthrax vaccines, rabies vaccine, brucellosis vaccine, DA2PPC vaccine, clostridium vaccine, and others.
Based on the product type, the market is further segmented as companion animal, porcine, livestock, equine, poultry, aquaculture, and other animal vaccines. Owing to the rising number of pet owners worldwide, the companion animal segment proves to be largest and the fastest growing segment in the global market.
Report Attributes | Report Details |
---|---|
Report Name | Animal Vaccines Market Research Report |
Market Size in 2023 | USD 14.44 Billion |
Market Forecast in 2032 | USD 31.76 Billion |
Growth Rate | CAGR of 9.28% |
Number of Pages | 218 |
Key Companies Covered | Merck Animal Health, Bayer Healthcare Novartis, Bimeda Inc., Ceva Sante Animale, Eli Lilly and Company, and Zoetis. Other key players who dominate the market are Sanofi-Aventis, Boehringer Ingelheim GmbH, and Virbac Inc. |
Segments Covered | By Type of Vaccine, By Disease Category, By Product Type And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific is experiencing the highest growth in the global market owing to its increased consumption and trade of meat. This trend is followed by China due to its rising consumption of meat. The global animal vaccines market is dominated by North America followed by Europe and Asia-Pacific.
The global animal vaccines market is dominated by players like:
By Type of Vaccine
By Disease Category
By Product Type
Animal Vaccines Market: Regional Segment Analysis
FrequentlyAsked Questions
One of the most significant compromises in disease prevention that has ever been devised is vaccination.The reduction in disease is indicative of the efficacy of vaccination. Rabies, feline panleukopenia, feline viral rhinotracheitis, feline calicivirus infection, canine distemper, canine parvovirus infection, and canine hepatitis are among the numerous diseases that animal vaccines protect against.
Large, controlled dispute studies that are mandatory prior to the release of human vaccines are not necessary for animal vaccines. The US Department of Agriculture regulates animal vaccines, but it does not necessitate that the vaccines be demonstrated to be safe and unadulterated, or that they have a "reasonable expectation" of efficacy, prior to their release.However, the licensing process may not inherently guarantee the clinical relevance or applicability of a specific vaccine. This fact facilitates the production of animal vaccines and the fulfillment of the expanding global market demand.
The global animal vaccines market size was worth around USD 14.44 billion in 2023 and is predicted to grow to around USD 31.76 billion by 2032.
The global animal vaccines market a compound annual growth rate (CAGR) of roughly 9.28% between 2024 and 2032.
Asia Pacific is experiencing the highest growth in the global market owing to its increased consumption and trade of meat. This trend is followed by China due to its rising consumption of meat. The global animal vaccines market is dominated by North America followed by Europe and Asia-Pacific.
Major players of the animal vaccines market include Merck Animal Health, Bayer Healthcare Novartis, Bimeda Inc., Ceva Sante Animale, Eli Lilly and Company, and Zoetis. Other key players who dominate the market are Sanofi-Aventis, Boehringer Ingelheim GmbH, and Virbac Inc.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed